Company Overview: Newmont Corporation (NYSE: NEM) is a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, Papua New Guinea, Ecuador, Fiji and Ghana. Its operations include Brucejack, Red Chris, Penasquito, Merian, Cerro Negro, Yanacocha, Boddington, Tanami, Cadia, Lihir, Ahafo, and NGM.
As per our previous US Inflation Report published on ‘NEM’ on 28th March 2025, Kalkine provided a ‘Buy’ stance on the stock at USD 48.39, based on “Newmont Corporation’s (NEM) robust fundamentals, significant production of 6.8 million gold ounces in 2024, a 106% surge in Adjusted EBITDA to USD8.7 billion, strong operational momentum with a record USD2.9 billion in Free Cash Flow, financial resilience from USD7.7 billion in total liquidity, strategic portfolio optimization through divestitures expected to yield up to USD4.3 billion, and a current valuation reflecting stability amidst a favourable gold price environment”, giving a return of 14.23%, attaining resistance 1 and moving towards resistance 2.
Current Macro and company specific rationales:
Noted below are the details of support and resistance levels provided in our previous report:

Relative Valuation (Price/Earnings based relative valuation):

NEM’s Daily Chart

Considering the current trading levels, volatile macro environment, lower intrinsic value as per P/E relative valuation, tariffs increased both by US and China, and risks associated, a ‘Sell’ rating is assigned to the “NEM” at the current market price of USD 55.24, as of April 11, 2025, at 09:40 am PDT.
Note: This report may be updated with details around fundamental and technical analysis, price/ chart in due course, as appropriate
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is April 11, 2025. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.